Fanskya

mozafancogene autotemcel · Rocket Pharmaceuticals B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fanskya, covering 2025-10-27 to 2025-10-27. Get the full timeline:

Most recent: EMA Application withdrawn: Fanskya (mozafancogene autotemcel) — Rocket Pharmaceuticals B.V.